Recovery of <i>Saccharomyces cerevisiae</i> CNCM I-3856 in Vaginal Samples of Healthy Women after Oral Administration
Bacterial vaginosis and vulvovaginal candidiasis are common causes of impaired health and quality of life for women. Although antimicrobial agents remain the main strategy for the treatment of vaginal infections, their repeated use involves high rates of resistance and recurrence. Alternative approa...
Main Authors: | Amelie Decherf, Elodie Dehay, Mickaël Boyer, Mathieu Clément-Ziza, Bertrand Rodriguez, Sophie Legrain-Raspaud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/8/2211 |
Similar Items
-
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
by: Elena Roselletti, et al.
Published: (2019-07-01) -
Anti-Biofilm Properties of <i>Saccharomyces cerevisiae </i>CNCM I-3856 and <i>Lacticaseibacillus rhamnosus </i>ATCC 53103 Probiotics against <i>G. vaginalis</i>
by: Samuele Sabbatini, et al.
Published: (2020-08-01) -
Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections
by: Roberta Gaziano, et al.
Published: (2020-04-01) -
Multi-targeted properties of the probiotic saccharomyces cerevisiae CNCM I-3856 against enterotoxigenic escherichia coli (ETEC) H10407 pathogenesis across human gut models
by: Charlène Roussel, et al.
Published: (2021-01-01) -
Strain-Specific Responses by <i>Saccharomyces cerevisiae</i> to Competition by Non-<i>Saccharomyces</i> Yeasts
by: Cristobal A. Onetto, et al.
Published: (2021-08-01)